Orange Book product · Generic (ANDA)
DEXACIDIN
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
At a glance
Feb 22, 1985
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 22, 1985
41 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength
0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Dosage form
OINTMENT
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 062566
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- —MAXITROLBrand (NDA)
NDA 050065 · SANDOZ
- —MAXITROLBrand (NDA)
NDA 050023 · HARROW EYE
- 1995DEXASPORINGeneric (ANDA)
ANDA 064135 · BAUSCH AND LOMB INC
- 1994NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEGeneric (ANDA)
ANDA 064063 · BAUSCH AND LOMB INC
- 1989NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEGeneric (ANDA)
ANDA 062938 · PADAGIS US
- 1986NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEGeneric (ANDA)
ANDA 062721 · ALCON PHARMS LTD
- 1984DEXACIDINGeneric (ANDA)
ANDA 062544 · NOVARTIS
- 1984MAXITROLGeneric (ANDA)
ANDA 062341 · SANDOZ
- 1983DEXASPORINGeneric (ANDA)
ANDA 062428 · PHARMAFAIR
- 1983DEXASPORINGeneric (ANDA)
ANDA 062411 · PHARMAFAIR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
